Why PanGIA Biotech’s urine biopsy data may matter more than the headline sensitivity figure suggests
PanGIA Biotech reported 97.8% sensitivity in a urine-based prostate cancer study. Read what the data changes and what risks still remain.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Why Better Life Science’s Lyme testing push matters more for access than for diagnosis alone
Better Life Science is pushing at-home Lyme testing this spring. Read what Tick Bite Hero changes, where it fits, and what risks remain.
Medical Devices & Diagnostics
Can EarliPoint Health and Netsmart reduce autism diagnosis bottlenecks in provider settings?
EarliPoint Health and Netsmart are expanding access to autism assessment technology. Read what this could change for providers, workflows, and adoption.
Medical Devices & Diagnostics
OpenEvidence expands beyond search as Tandem partnership pushes medical AI into prescription access workflows
OpenEvidence and Tandem are linking clinical AI with prior authorization automation. Read what this could change for prescribing, access, and workflow.
Medical Devices & Diagnostics
Can VR LIFE and H2 Global Group turn European MedTech validation into real global scale?
Can VR LIFE and H2 Global Group scale from European validation to global MedTech relevance? Read the deeper analysis now.
Medical Devices & Diagnostics
Can Allevion Medical’s Vantage change spinal stenosis workflows by combining disposable access, illumination, and bone resection tools?
Allevion Medical’s Vantage won FDA 510(k) clearance for lumbar decompression. Read what this may change for spinal stenosis workflow, adoption, and risk.
Medical Devices & Diagnostics
Spacelabs Healthcare links Rothman Index to DEPTH Health as hospitals chase faster, safer bed movement
Spacelabs Healthcare and DEPTH Health are pairing Rothman Index analytics with patient flow tools. Read what this could change for hospitals.
Medical Devices & Diagnostics
How ATL Medical’s PREVOYANCE imaging system could speed arthroscopy device development with OMNIVISION’s OH0131 processor
ATL Medical and OMNIVISION have expanded arthroscopy imaging integration. Read what this means for OEM speed, quality, and device development.
Medical Devices & Diagnostics
Can Peri turn perimenopause tracking into a credible new women’s health device category?
Peri has launched a perimenopause wearable, but can symptom tracking become clinical-grade insight? Read the deeper industry analysis now.
Medical Devices & Diagnostics
Why the Ro and Eli Lilly KwikPen move matters for obesity drug access, adherence, and pricing
Ro launches Eli Lilly’s Zepbound KwikPen nationwide. Read what this means for GLP-1 access, pricing, adherence, and obesity care models.